<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(3)</volume><submitter>Shin JH</submitter><pubmed_abstract>BACKGROUND/PURPOSE:The purpose of this study was to evaluate the utility and efficacy of combined low-dose, time-resolved (TR) and single-phase high-resolution (HR) contrast-enhanced MRA (CE-MRA) as a pre-angiographic study for spinal vascular disease. MATERIALS AND METHODS:Seventeen consecutive patients with suspected spinal vascular disease were retrospectively reviewed. All patients underwent combined low-dose TR CE-MRA and three-dimensional single-phase HR CE-MRA at 3 Tesla, followed by conventional spinal digital subtraction angiography (DSA) within 90 days. Six patients underwent additional spinal MRA and DSA for treatment follow-up. Spinal lesions were analyzed in terms of presence, disease type, laterality, spinal level, and number of arterial feeders. RESULTS:Low-dose TR CE-MRA he</pubmed_abstract><journal>PloS one</journal><pagination>e0214289</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6438605</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Diagnostic accuracy and efficiency of combined acquisition of low-dose time-resolved and single-phase high-resolution contrast-enhanced magnetic resonance angiography in a single session for pre-angiographic evaluation of spinal vascular disease.</pubmed_title><pmcid>PMC6438605</pmcid><pubmed_authors>Shin JH</pubmed_authors><pubmed_authors>Jung SL</pubmed_authors><pubmed_authors>Shin NY</pubmed_authors><pubmed_authors>Ahn K</pubmed_authors><pubmed_authors>Kim BS</pubmed_authors><pubmed_authors>Choi HS</pubmed_authors><pubmed_authors>Choi Y</pubmed_authors><pubmed_authors>Jang J</pubmed_authors><pubmed_authors>Park B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Diagnostic accuracy and efficiency of combined acquisition of low-dose time-resolved and single-phase high-resolution contrast-enhanced magnetic resonance angiography in a single session for pre-angiographic evaluation of spinal vascular disease.</name><description>BACKGROUND/PURPOSE:The purpose of this study was to evaluate the utility and efficacy of combined low-dose, time-resolved (TR) and single-phase high-resolution (HR) contrast-enhanced MRA (CE-MRA) as a pre-angiographic study for spinal vascular disease. MATERIALS AND METHODS:Seventeen consecutive patients with suspected spinal vascular disease were retrospectively reviewed. All patients underwent combined low-dose TR CE-MRA and three-dimensional single-phase HR CE-MRA at 3 Tesla, followed by conventional spinal digital subtraction angiography (DSA) within 90 days. Six patients underwent additional spinal MRA and DSA for treatment follow-up. Spinal lesions were analyzed in terms of presence, disease type, laterality, spinal level, and number of arterial feeders. RESULTS:Low-dose TR CE-MRA he</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-26T21:37:30.052Z</modification><creation>2020-10-09T07:31:14Z</creation></dates><accession>S-EPMC6438605</accession><cross_references><pubmed>30921365</pubmed><doi>10.1371/journal.pone.0214289</doi></cross_references></HashMap>